Skip to content

Clinical trials

Phase 3 Heart Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Phase: Phase 3 Country / region: United Kingdom Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20091
20101
20131
20151
20182
20191
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eidos Therapeutics, a BridgeBio company2
Eli Lilly and Company2
GlaxoSmithKline2
Alder Hey Children's NHS Foundation Trust1
Alexion Pharmaceuticals, Inc.1
AstraZeneca1
Bayer1
CSL Behring1
Daiichi Sankyo1
Idorsia Pharmaceuticals Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases14
Cardiovascular Diseases5
Atherosclerosis4
Stroke4
Acute Coronary Syndrome3
Coronary Artery Disease3
Peripheral Arterial Disease3
Renal Insufficiency, Chronic3
Alzheimer Disease2
Amyloid Neuropathies, Familial2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.